Investors are deploying less capital in biotech startups as a cloudy market outlook and a dearth of IPOs hobble the sector.
Source link
Venture Interest Slackens in Once-Hot Biotech
Related Posts
The first of China’s ‘AI tigers’ goes public as Zhipu climbs in Hong Kong debut
The Zhipu AI emblem is seen displayed on a smartphone display. Sopa Photos | Lightrocket | Getty Photos Shares of…
Salesforce (CRM) Q2 earnings report 2026
Marc Benioff, co-founder and CEO of Salesforce, sits for an interview in San Francisco on April 25, 2025. David Paul…
AI, Big Tech bull case despite Nasdaq’s worst week since April
State Avenue is reiterating its bullish stance on the factitious intelligence commerce regardless of the Nasdaq’s worst week since April.…